相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Single-cell RNA profiling identifies diverse cellular responses to EWSR1/FLI1 downregulation in Ewing sarcoma cells
Roxane Khoogar et al.
CELLULAR ONCOLOGY (2022)
Combinatorial strategies to potentiate the efficacy of HDAC inhibitors in fusion-positive sarcomas
Cinzia Lanzi et al.
BIOCHEMICAL PHARMACOLOGY (2022)
Making sense of the ageing methylome
Kirsten Seale et al.
NATURE REVIEWS GENETICS (2022)
Chromatin profiling reveals relocalization of lysine-specific demethylase 1 by an oncogenic fusion protein
Emily R. Theisen et al.
EPIGENETICS (2021)
The epigenetic basis of cellular heterogeneity
Benjamin Carter et al.
NATURE REVIEWS GENETICS (2021)
STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma
Didier Surdez et al.
CANCER CELL (2021)
LSD1: Expanding Functions in Stem Cells and Differentiation
Carlos Martinez-Gamero et al.
CELLS (2021)
A first-generation pediatric cancer dependency map
Neekesh Dharia et al.
NATURE GENETICS (2021)
STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma
Biniam Adane et al.
CANCER CELL (2021)
TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma
Bo Kyung A. Seong et al.
CANCER CELL (2021)
TK216 for relapsed/refractory Ewing sarcoma: Interim phase 1/2 results.
Joseph Aloysius Ludwig et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
High-resolution characterization of gene function using single-cell CRISPR tiling screen
Lu Yang et al.
NATURE COMMUNICATIONS (2021)
Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma
Hai-Feng Zhang et al.
CANCER DISCOVERY (2021)
Therapeutic Potential of EWSR1-FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma
Saint T. Cervera et al.
CANCERS (2021)
Identification of a New Transcriptional Co-Regulator of STEAP1 in Ewing's Sarcoma
Fatu Badiane Markey et al.
CELLS (2021)
Transcriptional Programs Define Intratumoral Heterogeneity of Ewing Sarcoma at Single-Cell Resolution
Marie-Ming Aynaud et al.
CELL REPORTS (2020)
RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis
Sara Sanchez-Molina et al.
SCIENCE ADVANCES (2020)
The Promoter-Associated Noncoding RNA pncCCND1_B Assembles a Protein-Complex to Regulate Cyclin D1 Transcription in Ewing Sarcoma
Ramona Palombo et al.
CANCER RESEARCH (2019)
High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma
Sarah Wang et al.
CLINICAL CANCER RESEARCH (2019)
The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents
Filippo Spriano et al.
CLINICAL CANCER RESEARCH (2019)
Small molecule inhibition of lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) alone and in combination in Ewing sarcoma cell lines
Darcy Welch et al.
PLOS ONE (2019)
Chromatin accessibility and the regulatory epigenome
Sandy L. Klemm et al.
NATURE REVIEWS GENETICS (2019)
Super-enhancer-associated MEIS1 promotes transcriptional dysregulation in Ewing sarcoma in co-operation with EWS-FLI1
Lehang Lin et al.
NUCLEIC ACIDS RESEARCH (2019)
Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response
Kathleen I. Pishas et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Targeting Histone Deacetylase Activity to Arrest Cell Growth and Promote Neural Differentiation in Ewing Sarcoma
Barbara Kunzler Souza et al.
MOLECULAR NEUROBIOLOGY (2018)
Ewing sarcoma
Thomas G. P. Gruenewald et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Epigenome editing of microsatellite repeats defines tumor-specific enhancer functions and dependencies
Gaylor Boulay et al.
GENES & DEVELOPMENT (2018)
Genome-scale CRI SPR-Cas9 screen identifies druggable dependencies in TP53 wild-type Ewing sarcoma
Bjorn Stolte et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma
Daniel Jose García-Domínguez et al.
Oncotarget (2018)
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth
Janet K. Parrish et al.
Oncotarget (2018)
Super-resolution chromatin tracing reveals domains and cooperative interactions in single cells
Bogdan Bintu et al.
SCIENCE (2018)
Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors
Austin McCuiston et al.
HEAD & NECK PATHOLOGY (2018)
Combinatorial Drug Screening Identifies Ewing Sarcoma-specific Sensitivities
Branka Radic-Sarikas et al.
MOLECULAR CANCER THERAPEUTICS (2017)
EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma
F. Cidre-Aranaz et al.
ONCOGENE (2017)
The potential of KDM3A as a therapeutic target in Ewing Sarcoma and other cancers
Paul Jedlicka
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability
Tao He et al.
GENE (2017)
Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells
G-A Franzetti et al.
ONCOGENE (2017)
The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis
M. Sechler et al.
ONCOGENE (2017)
Identification of two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma
Kirsten M. Johnson et al.
PLOS ONE (2017)
Role for the EWS domain of EWS/FLI in binding GGAA-microsatellites required for Ewing sarcoma anchorage independent growth
Kirsten M. Johnson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain
Gaylor Boulay et al.
CELL (2017)
Multi-omics approaches to disease
Yehudit Hasin et al.
GENOME BIOLOGY (2017)
MEIS1-mediated transactivation of synaptotagmin-like 1 promotes CXCL12/CXCR4 signaling and leukemogenesis
Takashi Yokoyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
Andrew P. Feinberg et al.
NATURE REVIEWS GENETICS (2016)
The molecular hallmarks of epigenetic control
C. David Allis et al.
NATURE REVIEWS GENETICS (2016)
RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-κB pathway, independently of the fusion oncoprotein
Inmaculada Hernandez-Munoz et al.
ONCOTARGET (2016)
Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting
Emily R. Theisen et al.
ONCOTARGET (2016)
Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma
Patrick J. Grohar et al.
CELL REPORTS (2016)
Upregulation of NKX2.2, a target of EWSR1/FLI1 fusion transcript, in primary renal Ewing sarcoma
Yoshinari Yamamoto et al.
JOURNAL OF CYTOLOGY (2015)
EWS-FLI1 employs an E2F switch to drive target gene expression
Raphaela Schwentner et al.
NUCLEIC ACIDS RESEARCH (2015)
Epigenome Mapping Reveals Distinct Modes of Gene Regulation and Widespread Enhancer Reprogramming by the Oncogenic Fusion Protein EWS-FLI1
Eleni M. Tomazou et al.
CELL REPORTS (2015)
Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics
Cigall Kadoch et al.
SCIENCE ADVANCES (2015)
Regulation of gene transcription by Polycomb proteins
Sergi Aranda et al.
SCIENCE ADVANCES (2015)
The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma
J. K. Parrish et al.
ONCOGENE (2015)
EWS-FLI1 Utilizes Divergent Chromatin Remodeling Mechanisms to Directly Activate or Repress Enhancer Elements in Ewing Sarcoma
Nicolo Riggi et al.
CANCER CELL (2014)
Reversible LSD1 Inhibition Interferes with Global EWS/ETS Transcriptional Activity and Impedes Ewing Sarcoma Tumor Growth
Savita Sankar et al.
CLINICAL CANCER RESEARCH (2014)
Blocking SDF-1α/CXCR4 Downregulates PDGF-B and Inhibits Bone Marrow-Derived Pericyte Differentiation and Tumor Vascular Expansion in Ewing Tumors
Randala Hamdan et al.
MOLECULAR CANCER THERAPEUTICS (2014)
An AUTS2-Polycomb complex activates gene expression in the CNS
Zhonghua Gao et al.
NATURE (2014)
Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma
S. Niedan et al.
ONCOGENE (2014)
Clinical and Biochemical Function of Polymorphic NR0B1 GGAA-Microsatellites in Ewing Sarcoma: A Report from the Children's Oncology Group
Michael J. Monument et al.
PLOS ONE (2014)
The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma
Ryo Shibuya et al.
VIRCHOWS ARCHIV (2014)
The Genomic Landscape of Pediatric Ewing Sarcoma
Brian D. Crompton et al.
CANCER DISCOVERY (2014)
High-Throughput Tyrosine Kinase Activity Profiling Identifies FAK as a Candidate Therapeutic Target in Ewing Sarcoma
Brian D. Crompton et al.
CANCER RESEARCH (2013)
Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer
Sven Bilke et al.
GENOME RESEARCH (2013)
Frequent truncating mutations of STAG2 in bladder cancer
David A. Solomon et al.
NATURE GENETICS (2013)
Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy
Cristina Balbas-Martinez et al.
NATURE GENETICS (2013)
Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma
S. Sankar et al.
ONCOGENE (2013)
The interleukin-1 receptor family
Diana Boraschi et al.
SEMINARS IN IMMUNOLOGY (2013)
NKX2.2 is a Useful Immunohistochemical Marker for Ewing Sarcoma
Akihiko Yoshida et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38MAPK and c-Jun N-terminal kinase
Shuai Zhang et al.
ANTI-CANCER DRUGS (2012)
Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma
Aleksandar Boro et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
STEAP1 Is Associated with the Invasive and Oxidative Stress Phenotype of Ewing Tumors
Thomas G. P. Grunewald et al.
MOLECULAR CANCER RESEARCH (2012)
Microsatellites with Macro-Influence in Ewing Sarcoma
Michael J. Monument et al.
GENES (2012)
The rationale for targeting the LOX family in cancer
Holly E. Barker et al.
NATURE REVIEWS CANCER (2012)
Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors
Hans-Ulrich Schildhaus et al.
HUMAN PATHOLOGY (2011)
Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers
Shinya Hayami et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway
Elspeth M. Beauchamp et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Identification of an Inhibitor of the EWS-FLI1 Oncogenic Transcription Factor by High-Throughput Screening
Patrick J. Grohar et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Modeling Initiation of Ewing Sarcoma in Human Neural Crest Cells
Cornelia von Levetzow et al.
PLOS ONE (2011)
FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells
Liu Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology
Soyoung Lim et al.
CARCINOGENESIS (2010)
EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells
Nicolo Riggi et al.
GENES & DEVELOPMENT (2010)
RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma
Shilpi Arora et al.
MOLECULAR CANCER (2010)
Mediator and cohesin connect gene expression and chromatin architecture
Michael H. Kagey et al.
NATURE (2010)
EWS/FLI and Its Downstream Target NR0B1 Interact Directly to Modulate Transcription and Oncogenesis in Ewing's Sarcoma
Michelle Kinsey et al.
CANCER RESEARCH (2009)
Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2
Stefan Burdach et al.
CELL CYCLE (2009)
GLI1 Is a Direct Transcriptional Target of EWS-FLI1 Oncoprotein
Elspeth Beauchamp et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma
Hayriye V. Erkizan et al.
NATURE MEDICINE (2009)
The Oncogenic EWS-FLI1 Protein Binds In Vivo GGAA Microsatellite Sequences with Potential Transcriptional Activation Function (Publication with Expression of Concern. See vol. 17, 2022)
Noelle Guillon et al.
PLOS ONE (2009)
A Molecular Function Map of Ewing's Sarcoma
Maximilian Kauer et al.
PLOS ONE (2009)
GLI1 Is a Central Mediator of EWS/FLI1 Signaling in Ewing Tumors
Jay Joo et al.
PLOS ONE (2009)
EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation
Guenther H. S. Richter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
p53 and E2f: partners in life and death
Shirley Polager et al.
NATURE REVIEWS CANCER (2009)
EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells
Nicolo Riggi et al.
CANCER RESEARCH (2008)
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Jeffrey A. Simon et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
The cohesin ring concatenates sister DNA molecules
Christian H. Haering et al.
NATURE (2008)
DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells
E. Garcia-Aragoncillo et al.
ONCOGENE (2008)
EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing's Sarcoma
Leah A. Owen et al.
PLOS ONE (2008)
Microsatellites as EWIS/FLI response elements in Ewing's sarcoma
Kunal Gangwal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The EWS/FLI1 oncogenic transcription factor deregulates GLI1
J. P. Zwerner et al.
ONCOGENE (2008)
Mesenchymal stem cell features of Ewing tumors
Franck Tirode et al.
CANCER CELL (2007)
Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma
Kimberly Stegmaier et al.
PLOS MEDICINE (2007)
HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity
Virginie Clement et al.
CURRENT BIOLOGY (2007)
Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence
Philip Kahl et al.
CANCER RESEARCH (2006)
Expression of EWS-ETS fusions in NIH3T3 cells reveals significant differences to Ewing's sarcoma
Chi L. Braunreiter et al.
CELL CYCLE (2006)
NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma
Michelle Kinsey et al.
MOLECULAR CANCER RESEARCH (2006)
Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A
Jeffrey A. Toretsky et al.
CANCER RESEARCH (2006)
Polycomb complexes repress developmental regulators in murine embryonic stem cells
LA Boyer et al.
NATURE (2006)
JHDM2A, a JmjC-containing H3K9 dernethylase, facilitates transcription activation by androgen receptor
Kenichi Yamane et al.
CELL (2006)
Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma
Richard Smith et al.
CANCER CELL (2006)
The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors
M Mendiola et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
GLI transcription factors: Mediators of oncogenic Hedgehog signalling
M Kasper et al.
EUROPEAN JOURNAL OF CANCER (2006)
Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells
N Riggi et al.
CANCER RESEARCH (2005)
Antitumor effects of histone deacetylase inhibitor on Ewing's family tumors
R Sakimura et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors
S Hu-Lieskovan et al.
CANCER RESEARCH (2005)
FoxO1 stimulates fatty acid uptake and oxidation in muscle cells through CD36-dependent and -independent mechanisms
CC Bastie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3
A Prieur et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex
R Cao et al.
MOLECULAR CELL (2004)
DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets
MS Staege et al.
CANCER RESEARCH (2004)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation
E Lalli et al.
MOLECULAR ENDOCRINOLOGY (2003)
PIM3 proto-oncogene kinase is a common transcriptional target of divergent EWS/IETS oncoproteins
B Deneen et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Identification of p21WAF1/CIP1 as a direct target of EWS-Fli1 oncogenic fusion protein
F Nakatani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma
M Fukuma et al.
ONCOGENE (2003)
Alteration of mesodermal cell differentiation by EWS/FLI-1, the oncogene implicated in Ewing's sarcoma
S Eliazer et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts
SL Lessnick et al.
CANCER CELL (2002)
分享论文
